Utilities of next-generation sequencing in the surgical management of thyroid nodules in China
Open Access
- 5 March 2026
- journal article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Abstract
This study aimed to evaluate the diagnostic utility of next-generation sequencing (NGS) for identifying genetic alterations in fine-needle aspiration (FNA) samples from thyroid nodules, with a specific focus on its clinical implications for surgical management. In total, 631 patients underwent FNA cytology, yielding 683 cytological samples. Of these, 264 patients with indeterminate or suspicious cytological results underwent surgical intervention, and their samples were subjected to molecular analysis targeting single-nucleotide variants (SNVs) and insertion/deletion (InDel) mutations in a 20-gene panel associated with thyroid carcinoma. Genetic alterations were identified in 160 (57.55%) nodules, while 118 (42.45%) exhibited no detectable mutations. Co-occurrence of multiple genetic mutations was noted in 39 nodules (14.03%). When noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) and tumors with uncertain malignant potential were considered malignant, the NGS test demonstrated a sensitivity of 66.67% (95% CI: 49.69%–80.41%) and specificity of 72.34% (95% CI: 57.13%–83.91%) specifically for nodules with indeterminate cytology (Bethesda categories III and IV). The BRAF V600E mutation was the most frequently observed genetic alteration in papillary thyroid carcinoma (PTC). The classic subtype of papillary thyroid carcinoma (PTC) was the most prevalent, followed by the infiltrative follicular variant and the tall cell subtype. The tall cell subtype showed strong associations with key molecular alterations, including BRAF V600E, TERT promoter, and TP53 mutations. These findings highlight the potential of NGS-based molecular profiling to enhance diagnostic accuracy, inform risk stratification, and guide personalized surgical approaches in thyroid nodule management.Keywords
This publication has 38 references indexed in Scilit:
- 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADSEndocrine, 2020
- Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytologyEndocrine, 2019
- Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate CytologyJAMA Oncology, 2019
- Benign call rate and molecular test result distribution of ThyroSeq v3Cancer Cytopathology, 2018
- Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid NodulesJAMA Surgery, 2018
- The Diagnosis and Management of Thyroid NodulesJAMA, 2018
- Genetic landscape of papillary thyroid carcinoma in the Chinese populationThe Journal of Pathology, 2017
- Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assayCancer, 2014
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid CancerJAMA, 2013
- Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science ConferenceDiagnostic Cytopathology, 2008